Assessment of IL‐1β, IL‐6, TNF‐α, IL‐8, and CCL 5 levels in newly diagnosed Saudi patients with rheumatoid arthritis. (24th June 2022)
- Record Type:
- Journal Article
- Title:
- Assessment of IL‐1β, IL‐6, TNF‐α, IL‐8, and CCL 5 levels in newly diagnosed Saudi patients with rheumatoid arthritis. (24th June 2022)
- Main Title:
- Assessment of IL‐1β, IL‐6, TNF‐α, IL‐8, and CCL 5 levels in newly diagnosed Saudi patients with rheumatoid arthritis
- Authors:
- Alturaiki, Wael
Alhamad, Abdulaziz
Alturaiqy, Muath
Mir, Shabir Ahmad
Iqbal, Danish
Bin Dukhyil, Abdul Aziz
Alaidarous, Mohammed
Alshehri, Bader
Alsagaby, Suliman A
Almalki, Sami G.
Alghofaili, Fayez
Choudhary, Ranjay K.
Almutairi, Saeedah
Banawas, Saeed
Alosaimi, Bandar
Mubarak, Ayman - Abstract:
- Abstract: Background: Rheumatoid arthritis (RA) is a chronic systemic inflammatory disorder which mainly affects small joints, occurs most commonly in middle‐aged adults, and can be fatal in severe cases. The exact etiology of RA remains unknown. However, uncontrolled expression of pro‐inflammatory cytokines and chemokines can contribute to the pathogenesis of RA. Aim: In the current study, we assessed the potential of serum concentrations of interleukin (IL)‐1β, IL‐6, tumor necrosis factor (TNF)‐α, IL‐8, and C‐C motif chemokine ligand (CCL)5 as early predictive markers for RA. Methods: In addition to clinical examination, blood samples were collected from 100 Saudi patients recently diagnosed with early RA for basic and serological tests, including rheumatoid factor (RF), C‐reactive protein (CRP), and erythrocyte sedimentation rate (ESR). Sera of 32 healthy individuals were used as controls. Specific enzyme‐linked immunosorbent assay was used to quantify the serum IL ‐ 1β, IL‐6, TNF‐α, IL‐8, and CCL5 levels in the samples. Results: Our results indicated that RF, CRP, and ESR levels were higher in RA patients compared to controls. Furthermore, serum levels of IL ‐ 1β, IL‐6, IL‐8, and CCL5, but not TNF‐α, significantly increased in RA patients compared to controls. Conclusion: Overall, the findings suggested that IL‐1β, IL‐6, IL‐8, and CCL5 can be used as biomarkers in the early diagnosis of RA.
- Is Part Of:
- International journal of rheumatic diseases. Volume 25:Number 9(2022)
- Journal:
- International journal of rheumatic diseases
- Issue:
- Volume 25:Number 9(2022)
- Issue Display:
- Volume 25, Issue 9 (2022)
- Year:
- 2022
- Volume:
- 25
- Issue:
- 9
- Issue Sort Value:
- 2022-0025-0009-0000
- Page Start:
- 1013
- Page End:
- 1019
- Publication Date:
- 2022-06-24
- Subjects:
- CCL5 -- IL‐1β -- IL‐6 -- IL‐8 -- rheumatoid arthritis (RA) -- TNF‐α
Rheumatology -- Periodicals
Rheumatology -- Asia -- Periodicals
Rheumatology -- Pacific Area -- Periodicals
Rheumatic Diseases -- Periodicals
Connective Tissue Diseases -- Periodicals
Immune System Diseases -- Periodicals
616.723 - Journal URLs:
- http://ejournals.ebsco.com/direct.asp?JournalID=715072 ↗
http://www.blackwell-synergy.com/loi/ijrd ↗
http://www.blackwellpublishing.com/aims.asp?ref=1756-1841&site=1 ↗
http://www3.interscience.wiley.com/journal/120118343/grouphome/home.html ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1756-185X ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/1756-185X.14373 ↗
- Languages:
- English
- ISSNs:
- 1756-1841
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.538180
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23305.xml